The continuum of personalized cardiovascular medicine: a position paper of the European Society of Cardiology

Standard

The continuum of personalized cardiovascular medicine: a position paper of the European Society of Cardiology. / Kirchhof, Paulus; Sipido, Karin R; Cowie, Martin R; Eschenhagen, Thomas; Fox, Keith A A; Katus, Hugo; Schroeder, Stefan; Schunkert, Heribert; Priori, Silvia; ESC CRT R&D and European Affairs Work Shop on Personalized Medicine.

in: EUR HEART J, Jahrgang 35, Nr. 46, 07.12.2014, S. 3250-3257.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Kirchhof, P, Sipido, KR, Cowie, MR, Eschenhagen, T, Fox, KAA, Katus, H, Schroeder, S, Schunkert, H, Priori, S & ESC CRT R&D and European Affairs Work Shop on Personalized Medicine 2014, 'The continuum of personalized cardiovascular medicine: a position paper of the European Society of Cardiology', EUR HEART J, Jg. 35, Nr. 46, S. 3250-3257. https://doi.org/10.1093/eurheartj/ehu312

APA

Kirchhof, P., Sipido, K. R., Cowie, M. R., Eschenhagen, T., Fox, K. A. A., Katus, H., Schroeder, S., Schunkert, H., Priori, S., & ESC CRT R&D and European Affairs Work Shop on Personalized Medicine (2014). The continuum of personalized cardiovascular medicine: a position paper of the European Society of Cardiology. EUR HEART J, 35(46), 3250-3257. https://doi.org/10.1093/eurheartj/ehu312

Vancouver

Bibtex

@article{ace5f9e4a8504b32a95b1efe6322770b,
title = "The continuum of personalized cardiovascular medicine: a position paper of the European Society of Cardiology",
abstract = "There is strong need to develop the current stratified practice of CVD management into a better personalized cardiovascular medicine, within a broad framework of global patient care. Clinical information obtained from history and physical examination, functional and imaging studies, biochemical biomarkers, genetic/epigenetic data, and pathophysiological insights into disease-driving processes need to be integrated into a new taxonomy of CVDs to allow personalized disease management. This has the potential for major health benefits for the population suffering from cardiovascular diseases.",
author = "Paulus Kirchhof and Sipido, {Karin R} and Cowie, {Martin R} and Thomas Eschenhagen and Fox, {Keith A A} and Hugo Katus and Stefan Schroeder and Heribert Schunkert and Silvia Priori and {ESC CRT R&D and European Affairs Work Shop on Personalized Medicine}",
year = "2014",
month = dec,
day = "7",
doi = "10.1093/eurheartj/ehu312",
language = "English",
volume = "35",
pages = "3250--3257",
journal = "EUR HEART J",
issn = "0195-668X",
publisher = "Oxford University Press",
number = "46",

}

RIS

TY - JOUR

T1 - The continuum of personalized cardiovascular medicine: a position paper of the European Society of Cardiology

AU - Kirchhof, Paulus

AU - Sipido, Karin R

AU - Cowie, Martin R

AU - Eschenhagen, Thomas

AU - Fox, Keith A A

AU - Katus, Hugo

AU - Schroeder, Stefan

AU - Schunkert, Heribert

AU - Priori, Silvia

AU - ESC CRT R&D and European Affairs Work Shop on Personalized Medicine

PY - 2014/12/7

Y1 - 2014/12/7

N2 - There is strong need to develop the current stratified practice of CVD management into a better personalized cardiovascular medicine, within a broad framework of global patient care. Clinical information obtained from history and physical examination, functional and imaging studies, biochemical biomarkers, genetic/epigenetic data, and pathophysiological insights into disease-driving processes need to be integrated into a new taxonomy of CVDs to allow personalized disease management. This has the potential for major health benefits for the population suffering from cardiovascular diseases.

AB - There is strong need to develop the current stratified practice of CVD management into a better personalized cardiovascular medicine, within a broad framework of global patient care. Clinical information obtained from history and physical examination, functional and imaging studies, biochemical biomarkers, genetic/epigenetic data, and pathophysiological insights into disease-driving processes need to be integrated into a new taxonomy of CVDs to allow personalized disease management. This has the potential for major health benefits for the population suffering from cardiovascular diseases.

U2 - 10.1093/eurheartj/ehu312

DO - 10.1093/eurheartj/ehu312

M3 - SCORING: Journal article

C2 - 25148837

VL - 35

SP - 3250

EP - 3257

JO - EUR HEART J

JF - EUR HEART J

SN - 0195-668X

IS - 46

ER -